Protandim IH1_Z AH0 ER1_B_AH0_L D_AY1_AH0_T_EH2_R_IY0 S_AH1_P_L_AH0_M_AH0_N_T M_AA1_R_K_AH0_T_AH0_D W_IH1_DH AH0_N_S_AH0_P_AO1_R_T_IH0_D K_L_EY1_M_Z DH_AE1_T IH1_T K_AE1_N T_R_IY1_T AH0 N_AH1_M_B_ER0 AH1_V M_EH1_D_AH0_K_AH0_L K_AH0_N_D_IH1_SH_AH0_N_Z The P_R_AA1_D_AH0_K_T IH1_Z AH0 P_AE1_T_AH0_N_T_AH0_D    M_IH1_K_S AH1_V F_AY1_V ER1_B_AH0_L IH2_N_G_R_IY1_D_IY0_AH0_N_T_S AH0_N_D S_OW1_L_D B_AY1 LifeVantage Corporation    F_AO1_R_M_ER0_L_IY0 LifeLine Therapeutics    Lifeline Nutraceuticals    AH0_N_D Yaak River Resources    Inc     AH0 Utah B_EY1_S_T M_AH1_L_T_IY0 L_EH1_V_AH0_L M_AA1_R_K_AH0_T_IH0_NG K_AH1_M_P_AH0_N_IY2    The M_AE2_N_Y_AH0_F_AE1_K_CH_ER0_ER0_Z AH1_V Protandim K_L_EY1_M IH1_T K_AE1_N P_R_IH0_V_EH1_N_T AO1_R K_Y_UH1_R AH0 W_AY1_D V_ER0_AY1_AH0_T_IY0 AH1_V M_EH1_D_AH0_K_AH0_L K_AH0_N_D_IH1_SH_AH0_N_Z    IH2_N_K_L_UW1_D_IH0_NG D_AY2_AH0_B_IY1_T_IY0_Z AH0_N_D K_AE1_N_S_ER0    In 2017    LifeVantage W_AA1_Z IH1_SH_UW0_D AH0 W_AO1_R_N_IH0_NG L_EH1_T_ER0 B_AY1 DH_AH0 Food AH0_N_D Drug Administration    FDA    R_AH0_G_AA1_R_D_IH0_NG IH2_L_IY1_G_AH0_L AE1_D_V_ER0_T_AY2_Z_IH0_NG K_L_EY1_M_Z AA1_N DH_AH0 K_AH1_M_P_AH0_N_IY2 EH1_S W_EH1_B_S_AY2_T_S S_AH0_JH_EH1_S_T_IH0_NG DH_AE1_T Protandim K_AE1_N HH_EH1_L_P T_UW1 K_Y_UH1_R V_EH1_R_IY0_AH0_S EY1_L_M_AH0_N_T_S    IH2_N_K_L_UW1_D_IH0_NG K_AE1_N_S_ER0 AH0_N_D D_AY2_AH0_B_IY1_T_IY0_Z      In 2003    Lifeline Therapeutics    AH0 P_R_AY1_V_AH0_T_L_IY0 HH_EH1_L_D Denver B_EY1_S_T nutraceutical L_AY1_S_AH0_N_S_IH0_NG AH0_N_D M_AA1_R_K_AH0_T_IH0_NG K_AH1_M_P_AH0_N_IY2    EH1_N_T_ER0_D IH1_N_T_UW0 AE1_N AH0_G_R_IY1_M_AH0_N_T W_IH1_DH Massachusetts B_AY2_OW0_T_EH2_K_N_AA1_L_AH0_JH_IY0 K_AH1_M_P_AH0_N_IY2 CereMedix F_AO1_R DH_AH0 R_AY1_T_S T_UW1 M_AA1_R_K_AH0_T CMX 1152    AE1_N IH0_K_S_P_EH2_R_IH0_M_EH1_N_T_AH0_L P_EH1_P_T_AY2_D B_EY1_S_T K_AA1_M_P_AW0_N_D    AH1_N_D_ER0 DH_AH0 B_R_AE1_N_D N_EY1_M    Protandim     AO1_L_S_OW0 S_AH0_M_T_AY1_M_Z R_AH0_F_ER1_D T_UW1 AE1_T DH_AE1_T T_AY1_M AE1_Z    Rholen      Rejuven8r    AH0_N_D    ependymin             CereMedix W_AA1_Z AH0 T_EH1_N P_ER0_S_EH1_N_T OW1_N_ER0 AH1_V Lifeline AH0_N_D M_EH1_M_B_ER0_Z AH1_V DH_AH0 CereMedix M_AE1_N_AH0_JH_M_AH0_N_T B_AO1_R_D S_ER1_V_D AA1_N Lifeline EH1_S B_AO1_R_D AH1_V D_ER0_EH1_K_T_ER0_Z CMX 1152 W_AA1_Z K_L_EY1_M_D T_UW1 upregulate DH_AH0 P_R_AH0_D_AH1_K_SH_AH0_N AH1_V DH_AH0 EH2_N_D_AO1_JH_EH0_N_AH0_S AE2_N_T_IY0_AA1_K_S_AH0_D_AH0_N_T EH1_N_Z_AY2_M_Z S_UW2_P_ER0_AA1_K_S_AY2_D D_IH2_S_M_Y_UW0_T_EY1_Z    catalase    AH0_N_D glutathione peroxidase    AH0_N_D T_UW1 AO0_F_S_EH1_T DH_AH0 ageing P_R_AA1_S_EH2_S    CMX 1152 W_AA1_Z D_UW1 T_UW1 B_IY1 M_AA1_R_K_AH0_T_AH0_D AE1_Z AE1_N OW1_V_ER0 DH_AH0 K_AW1_N_T_ER0 AE1_N_T_IY2 EY1_JH_IH0_NG P_IH1_L IH0_N June 2004 AE1_F_T_ER0 K_AH0_M_P_L_IY1_T_IH0_NG HH_Y_UW1_M_AH0_N K_L_IH1_N_AH0_K_AH0_L T_R_AY1_AH0_L_Z However    P_L_AE1_N_Z T_UW1 M_AA1_R_K_AH0_T DH_AH0 CMX 1152 V_ER1_ZH_AH0_N AH1_V Protandim F_EH1_L TH_R_UW1 AH0_N_D IH0_N April 2004 Lifeline Therapeutics AH0_N_AW1_N_S_T DH_AE1_T IH1_T W_UH1_D IH2_N_S_T_EH1_D B_IY1 M_AA1_R_K_AH0_T_IH0_NG AH0 D_IH1_F_ER0_AH0_N_T    N_AA1_N P_EH1_P_T_AY2_D    D_AY1_AH0_T_EH2_R_IY0 S_AH1_P_L_AH0_M_AH0_N_T AH1_N_D_ER0 DH_AH0 N_EY1_M  “ Protandim CF ”   T_UW1 D_IH0_S_T_IH1_NG_G_W_IH0_SH IH1_T F_R_AH1_M DH_AH0 P_EH1_P_T_AY2_D V_ER1_ZH_AH0_N IH2_N_IH1_SH_AH0_L_IY0 D_IH0_V_EH1_L_AH0_P_T B_AY1 Cermedix The N_UW1 V_ER1_ZH_AH0_N AH1_V Protandim    AH0 K_AA2_M_B_AH0_N_EY1_SH_AH0_N AH1_V K_AA1_M_AH0_N ER1_B_AH0_L IH2_N_G_R_IY1_D_IY0_AH0_N_T_S IH2_N_K_L_UW1_D_IH0_NG turmeric AH0_N_D G_R_IY1_N T_IY1 W_AA1_Z IH2_N_V_EH1_N_T_AH0_D F_AA1_L_OW0_IH0_NG  “ M_AH1_N_TH_S AH1_V IH0_K_S_T_EH1_N_S_IH0_V R_IY0_S_ER1_CH AH0_N_D D_IH0_V_EH1_L_AH0_P_M_AH0_N_T ”  B_AY1 Lifeline EH0_M_P_L_OY1_IY0_Z Paul Myhill AH0_N_D William Driscoll    AH0 F_AO1_R_M_ER0 OY1_L K_AH1_M_P_AH0_N_IY2 IH0_G_Z_EH1_K_Y_AH0_T_IH0_V     HH_UW1 T_AH0_G_EH1_DH_ER0 HH_OW1_L_D DH_AH0 P_AE1_T_AH0_N_T AA1_N DH_AH0 P_R_AA1_D_AH0_K_T     AH0_N_D IH1_T W_AA1_Z    L_AO1_N_CH_T IH0_N February 2005 Myhill AH0_N_D Driscoll R_IH0_Z_AY1_N_D F_R_AH1_M DH_AH0 K_AH1_M_P_AH0_N_IY2 L_EY1_T_ER0 DH_AE1_T Y_IH1_R       Like CMX 1152    DH_AH0 ER1_B_AH0_L M_IH1_K_S_CH_ER0 N_OW1_N AE1_Z Protandim DH_AE1_T S_AH0_P_L_AE1_N_T_AH0_D IH1_T W_AA1_Z M_AA1_R_K_AH0_T_AH0_D B_AY1 Lifeline AE1_Z AE1_N    AE1_N_T_IY2 EY1_JH_IH0_NG    S_AH1_P_L_AH0_M_AH0_N_T DH_AE1_T IH2_N_K_R_IY1_S_IH0_Z DH_AH0 B_AA1_D_IY0 EH1_S AE2_N_T_IY0_AA1_K_S_AH0_D_AH0_N_T D_IH0_F_EH1_N_S_AH0_Z B_AY1 upregulating S_UW2_P_ER0_AA1_K_S_AY2_D D_IH2_S_M_Y_UW0_T_EY1_Z    catalase    AH0_N_D glutathione peroxidase According T_UW1 DH_AH0 K_AH1_M_P_AH0_N_IY2    DH_AH0 P_R_AA1_D_AH0_K_T W_AA1_Z IH2_N_IH1_SH_AH0_L_IY0 S_OW1_L_D TH_R_UW1 R_IY1_T_EY2_L CH_AE1_N_AH0_L_Z S_AH1_CH AE1_Z GNC ;   HH_AW2_EH1_V_ER0    IH0_N 2009    AE1_F_T_ER0 S_EH1_V_ER0_AH0_L K_AH0_N_S_EH1_K_Y_AH0_T_IH0_V Y_IH1_R_Z AH1_V M_AH2_L_T_AY2_M_IH1_L_Y_AH0_N D_AA1_L_ER0 L_AO1_S_AH0_Z    DH_AH0 K_AH1_M_P_AH0_N_IY2     W_IH1_CH B_AY1 DH_EH1_N W_AA1_Z D_UW1_IH0_NG B_IH1_Z_N_AH0_S AH1_N_D_ER0 DH_AH0 N_EY1_M LifeVantage    S_T_AA1_P_T M_AA1_R_K_AH0_T_IH0_NG IH1_T TH_R_UW1 R_IY1_T_EY2_L_ER0_Z AH0_N_D S_W_IH1_CH_T T_UW1 M_AH1_L_T_IY0 L_EH1_V_AH0_L M_AA1_R_K_AH0_T_IH0_NG    S_EH1_L_IH0_NG IH1_T IH2_N_S_T_EH1_D TH_R_UW1 AH0 N_EH1_T_W_ER2_K AH1_V K_AH0_M_IH1_SH_AH0_N_D IH2_N_D_IH0_P_EH1_N_D_AH0_N_T D_IH0_S_T_R_IH1_B_Y_AH0_T_ER0_Z According T_UW1 LifeVantage    DH_AH0 M_UW1_V F_R_AH1_M R_IY1_T_EY2_L T_UW1 M_AH1_L_T_IY0 L_EH1_V_AH0_L M_AA1_R_K_AH0_T_IH0_NG W_AA1_Z P_R_AA1_M_P_T_AH0_D B_AY1 DH_AH0 January 2008 HH_AY1_R_IH0_NG AH1_V David Brown     F_AO1_R_M_ER0_L_IY0 CEO AH0_N_D P_R_EH1_Z_IH0_D_AH0_N_T AH1_V Metabolife    AE1_Z DH_AH0 K_AH1_M_P_AH0_N_IY2 EH1_S CEO AH0_N_D P_R_EH1_Z_IH0_D_AH0_N_T     Beginning IH0_N 2005    Protandim    W_AA1_Z P_R_AH0_D_UW1_S_T AH1_N_D_ER0 AH0 M_AE2_N_Y_AH0_F_AE1_K_CH_ER0_IH0_NG AH0_G_R_IY1_M_AH0_N_T W_IH1_DH The Chemins Company AH1_V Colorado Springs    Colorado    In July 2008    LifeVantage EH1_N_T_ER0_D IH1_N_T_UW0 AH0 N_UW1 M_AE2_N_Y_AH0_F_AE1_K_CH_ER0_IH0_NG AH0_G_R_IY1_M_AH0_N_T W_IH1_DH Cornerstone Research  &  Development T_UW1 P_R_AH0_D_UW1_S Protandim    AH0_N_D W_IH1_DH Wasatch Product Development T_UW1 P_R_AH0_D_UW1_S AH0 Protandim B_EY1_S_T S_K_IH1_N K_R_IY1_M    TrueScience    In 2006    B_AY2_OW0_K_EH1_M_IH0_S_T Joe McCord JH_OY1_N_D DH_AH0 LifeVantage B_AO1_R_D AH1_V D_ER0_EH1_K_T_ER0_Z AE1_Z DH_AH0 K_AH1_M_P_AH0_N_IY2 EH1_S Director AH1_V Science    McCord    HH_UW1 IH1_Z L_IH1_S_T_AH0_D B_AY1 DH_AH0 SEC AE1_Z AH0 LifeVantage IH2_N_S_AY1_D_ER0 SH_EH1_R_HH_OW2_L_D_ER0     S_ER1_V_D AE1_Z AH0 S_P_OW1_K_S_P_ER0_S_AH0_N F_AO1_R Protandim AH0_N_D W_AA1_Z R_IY0_S_P_AA1_N_S_AH0_B_AH0_L F_AO1_R D_IH0_S_T_R_IH1_B_Y_AH0_T_ER0 T_R_EY1_N_IH0_NG AH0_N_D P_R_AA1_D_AH0_K_T R_IY0_S_ER1_CH    Under DH_AH0 T_ER1_M_Z AH1_V HH_IH1_Z 2011 EH0_M_P_L_OY1_M_AH0_N_T AH0_G_R_IY1_M_AH0_N_T    McCord R_AH0_S_IY1_V_D  $ 529 994 IH0_N D_ER0_EH1_K_T K_AA2_M_P_AH0_N_S_EY1_SH_AH0_N AE1_Z W_EH1_L AE1_Z AH0 50 S_EH1_N_T K_AH0_M_IH1_SH_AH0_N AA1_N EH1_V_ER0_IY0 B_AA1_T_AH0_L AH1_V Protandim S_OW1_L_D     McCord S_ER1_V_D AE1_Z LifeVantage EH1_S Chief Scientific Officer F_R_AH1_M June 2011 AH0_N_T_IH1_L September 2012    AH0_N_D DH_EH1_N B_IH0_K_EY1_M AH0 M_EH1_M_B_ER0 AH1_V IH1_T_S S_AY1_AH0_N_S AE0_D_V_AY1_Z_ER0_IY0 B_AO1_R_D LifeVantage AH0_N_AW1_N_S_T McCord EH1_S R_IY0_T_AY1_ER0_M_AH0_N_T IH0_N June 2013     Under DH_AH0 T_ER1_M_Z AH1_V DH_AH0 S_EH2_P_ER0_EY1_SH_AH0_N AH0_G_R_IY1_M_AH0_N_T    McCord W_AA1_Z T_UW1 R_AH0_S_IY1_V AH0 P_EY1_M_AH0_N_T AH1_V  $ M_IH1_L_Y_AH0_N F_R_AH1_M DH_AH0 K_AH1_M_P_AH0_N_IY2    In January 2014    McCord W_AA1_Z R_IY2_P_L_EY1_S_T B_AY1 Shawn Talbott    D_IH0_V_EH1_L_AH0_P_ER0 AH1_V CortiSlim      HH_UW1 S_ER1_V_D AE1_Z DH_AH0 K_AH1_M_P_AH0_N_IY2 EH1_S Chief Science Officer    AH0_N_T_IH1_L B_IY1_IH0_NG R_IH0_L_IY1_V_D AH1_V HH_IH1_Z D_UW1_T_IY0_Z IH0_N June 2015    AH0_N_D R_IY2_P_L_EY1_S_T IH0_N August 2015 B_AY1 Natalie Chevreau    HH_UW1 W_AA1_Z HH_AY1_ER0_D AE1_Z DH_AH0 K_AH1_M_P_AH0_N_IY2 EH1_S Senior VP AH1_V Research AH0_N_D Development AH0_N_D IH1_Z K_R_EH1_D_AH0_T_AH0_D W_IH1_DH DH_AH0 IH2_N_V_EH1_N_SH_AH0_N AH1_V DH_AH0 K_AH1_M_P_AH0_N_IY2 EH1_S TruScience S_K_IH1_N K_EH1_R P_R_AA1_D_AH0_K_T    As R_IY1_S_AH0_N_T_L_IY0 AE1_Z July 21    2011    LifeVantage K_R_EH1_D_AH0_T_AH0_D McCord AE1_Z DH_AH0 K_R_IY0_EY1_T_ER0 AH1_V Protandim AA1_N IH1_T_S W_EH1_B_S_AY2_T    At AH0 2011 K_AA1_N_F_ER0_AH0_N_S F_AO1_R LifeVantage D_IH0_S_T_R_IH1_B_Y_AH0_T_ER0_Z    McCord S_T_EY1_T_IH0_D     W_AA1_Z P_R_IY0_Z_EH1_N_T_AH0_D W_IH1_DH AH0 L_IH1_S_T AH1_V 41 P_AH0_T_EH1_N_SH_AH0_L IH2_N_G_R_IY1_D_IY0_AH0_N_T_S F_AO1_R AH0 P_R_AA1_D_AH0_K_T DH_EY1 W_AO1_N_T_IH0_D T_UW1 K_AO1_L Protandim    AH0_N_D W_EH1_N_T TH_R_UW1 DH_AH0 L_IH1_S_T AH0_N_D P_EH1_N_S_AH0_L_D AW1_T    R_AE1_P_AH0_D_L_IY0    AH0_B_AW1_T 36 AH1_V DH_OW1_Z IH2_N_G_R_IY1_D_IY0_AH0_N_T_S     L_IY1_V_IH0_NG DH_AH0 IH2_N_G_R_IY1_D_IY0_AH0_N_T_S IH0_N DH_AH0 K_ER1_AH0_N_T F_AO2_R_M_Y_AH0_L_EY1_SH_AH0_N AH1_V Protandim    In March 2009    F_AO1_R_M_ER0 LifeLine Therapeutics IH0_G_Z_EH1_K_Y_AH0_T_IH0_V    Paul Myhill S_T_EY1_T_IH0_D     We IH2_N_IH1_SH_AH0_L_IY0 D_IH2_S_AY1_D_IH0_D T_UW1 HH_AY1_D DH_AE1_T F_AE1_K_T    DH_AE1_T Myhill D_ER0_AY1_V_D DH_AH0 K_AO1_R K_AA2_M_P_AH0_Z_IH1_SH_AH0_N F_AO1_R Protandim    F_AO1_R M_AA1_R_K_AH0_T_IH0_NG P_ER1_P_AH0_S_AH0_Z AH0_N_D IH2_N_S_T_EH1_D R_IH0_L_AY1 AA1_N DH_AH0 IH2_M_P_EH1_K_AH0_B_AH0_L B_AE1_K_G_R_AW2_N_D AH1_V Dr McCord      In April    2005    Myhill P_R_AH0_D_UW1_S_T AH0 S_AY1_N_D L_EH1_T_ER0 F_R_AH1_M McCord IH0_N W_IH1_CH McCord S_T_EY1_T_IH0_D     D_UW1 N_AA1_T AA1_N_AH0_S_T_L_IY0 F_IY1_L DH_AE1_T HH_AE1_V M_EY1_D K_AA2_N_T_R_AH0_B_Y_UW1_SH_AH0_N_Z T_UW1 DH_AH0 IH2_N_T_AH0_L_EH1_K_CH_UW0_AH0_L P_R_AA1_P_ER0_T_IY0    AH1_P T_UW1 DH_IH1_S P_OY1_N_T    DH_AE1_T W_UH1_D K_W_AA1_L_AH0_F_AY2 M_IY1 AE1_Z AE1_N IH2_N_V_EH1_N_T_ER0 M_AH1_S_T K_AH0_N_G_R_AE1_CH_AH0_L_EY2_T Y_UW1 AH0_N_D Paul F_AO1_R HH_AE1_V_IH0_NG F_R_EY1_M_D DH_AH0 K_AA1_N_S_EH0_P_T AH1_V Protandim S_OW1 K_L_OW1_S T_UW1 IH1_T_S F_AY1_N_AH0_L EH0_M_B_AA1_D_IY0_M_AH0_N_T    P_R_AY1_ER0 T_UW1 DH_AH0 B_IH0_G_IH1_N_IH0_NG_Z AH1_V AW1_ER0 AH0_S_OW2_S_IY0_EY1_SH_AH0_N     Protandim K_AH0_N_S_IH1_S_T_S M_EY1_N_L_IY0 AH1_V AH0 B_L_EH1_N_D AH1_V ER1_B_AH0_L IH2_N_G_R_IY1_D_IY0_AH0_N_T_S    AH0_M_AW1_N_T_S P_ER1 caplet L_IH1_S_T_AH0_D IH0_N P_ER0_EH1_N_TH_AH0_S_IY2_Z      Claims DH_AE1_T Protadim K_AE1_N P_R_IH0_V_EH1_N_T AO1_R T_R_IY1_T K_AE1_N_S_ER0 AA1_R AH0_N_P_R_UW1_V_AH0_N    Research IH1_N_T_UW0 Y_UW1_S AE1_Z AH0 T_R_IY1_T_M_AH0_N_T F_AO1_R AE2_M_AY0_AH0_T_R_OW1_F_IH0_K L_AE1_T_ER0_AH0_L S_K_L_ER0_OW1_S_AH0_S IH1_Z AH1_V P_UW1_R K_W_AA1_L_AH0_T_IY0    K_AE1_S_T_IH0_NG D_AW1_T AA1_N IH1_T_S Y_UW1_S_F_AH0_L_N_AH0_S F_AO1_R D_R_AO1_IH0_NG EH1_N_IY0 K_AH0_N_K_L_UW1_ZH_AH0_N_Z AH0_B_AW1_T EH1_F_IH0_K_AE2_S_IY0    In 2011    Harriet Hall R_OW1_T F_AO1_R Science Based Medicine DH_AE1_T     We S_IH1_M_P_L_IY0 D_AA1_N T_IY1 N_OW1 IH0_N_AH1_F AE1_T DH_IH1_S P_OY1_N_T T_UW1 R_EH2_K_AH0_M_EH1_N_D Protandim F_AO1_R T_R_IY1_T_M_AH0_N_T AO1_R P_R_IY0_V_EH1_N_SH_AH0_N AH1_V EH1_N_IY0 D_IH0_Z_IY1_Z    F_AO1_R AE1_N_T_IY2 EY1_JH_IH0_NG    F_AO1_R M_EY1_K_IH0_NG P_IY1_P_AH0_L F_IY1_L HH_EH1_L_TH_IY0_ER0 AO1_R M_AO1_R EH2_N_ER0_JH_EH1_T_IH0_K    AO1_R F_AO1_R EH1_N_IY0_TH_IH2_NG EH1_L_S     According T_UW1 DH_AH0 M_AE2_N_Y_AH0_F_AE1_K_CH_ER0_ER0    Protandim K_AE1_N K_AA1_Z AH0_L_ER1_JH_IH0_K R_IH0_S_P_AA1_N_S_IH0_Z    G_AE2_S_T_R_OW0_IH0_N_T_EH1_S_T_AH0_N_AH0_L D_IH0_S_T_ER1_B_AH0_N_S_AH0_Z    S_T_AH1_M_AH0_K EY1_K    D_AY2_ER0_IY1_AH0    V_AA1_M_AH0_T_IH0_NG     HH_EH1_D_EY2_K    AH0_N_D R_AE1_SH AH1_V DH_AH0 HH_AE1_N_D_Z AH0_N_D F_IY1_T     In December 2012    LifeVantage IH1_SH_UW0_D AH0 V_AA1_L_AH0_N_T_EH0_R_IY0 R_IY1_K_AO2_L AH1_V S_AH0_L_EH1_K_T L_AA1_T_S    10 L_AA1_T_S IH0_N T_OW1_T_AH0_L K_AH0_M_P_R_AY1_Z_IH0_NG 247 896 B_AA1_T_AH0_L_Z    AH1_V Protandim D_UW1 T_UW1 P_AH0_T_EH1_N_SH_AH0_L HH_EH1_L_TH R_IH1_S_K_S ER0_AY1_Z_IH0_NG F_R_AH1_M DH_AH0 P_AA1_S_AH0_B_AH0_L IH2_N_K_L_UW1_ZH_AH0_N AH1_V S_M_AO1_L M_EH1_T_AH0_L F_R_AE1_G_M_AH0_N_T_S IH0_N DH_AH0 F_AY1_N_AH0_L P_R_AA1_D_AH0_K_T      In February 2013    DH_AH0 K_AH1_M_P_AH0_N_IY2 AH0_N_AW1_N_S_T DH_AE1_T IH1_T W_AA1_Z IH0_K_S_T_EH1_N_D_IH0_NG DH_AH0 R_IY1_K_AO2_L T_UW1 IH2_N_K_L_UW1_D AH0_D_IH1_SH_AH0_N_AH0_L L_AA1_T_S AH1_V DH_AH0 P_R_AA1_D_AH0_K_T    EH1_S_T_AH0_M_EY2_T_IH0_NG DH_AH0 T_OW1_T_AH0_L K_AA1_S_T AH1_V DH_AH0 R_IY1_K_AO2_L AE1_T  $ M_IH1_L_Y_AH0_N    On April 17    2017    LifeVantage W_AA1_Z IH1_SH_UW0_D AH0 W_AO1_R_N_IH0_NG L_EH1_T_ER0 B_AY1 DH_AH0 Food AH0_N_D Drug Administration    FDA    R_AH0_G_AA1_R_D_IH0_NG IH2_L_IY1_G_AH0_L AE1_D_V_ER0_T_AY2_Z_IH0_NG K_L_EY1_M_Z AA1_N DH_AH0 K_AH1_M_P_AH0_N_IY2 EH1_S W_EH1_B_S_AY2_T_S S_AH0_JH_EH1_S_T_IH0_NG DH_AE1_T Protandim K_AE1_N P_L_EY1 AH0 R_OW1_L IH0_N HH_EH1_L_P_IH0_NG T_UW1 K_Y_UH1_R V_EH1_R_IY0_AH0_S EY1_L_M_AH0_N_T_S    IH2_N_K_L_UW1_D_IH0_NG K_AE1_N_S_ER0 AH0_N_D D_AY2_AH0_B_IY1_T_IY0_Z The K_L_EY1_M_Z W_ER1 D_IY1_M_D T_UW1 B_IY1 IH0_N V_AY0_AH0_L_EY1_SH_AH0_N AH1_V Section 201 JH_IY1          AH1_V DH_AH0 Federal Food    Drug    AH0_N_D Cosmetic Act    DH_AH0 Act     21  §  321 JH_IY1               In 2009    LifeVantage W_AA1_Z S_UW1_D B_AY1 Utah B_EY1_S_T Zrii LLC    AH0 M_AA1_R_K_AH0_T_ER0 AH1_V N_UW0_T_R_IH1_SH_AH0_N_AH0_L F_R_UW1_T D_R_IH1_NG_K_S EH0_N_D_AO1_R_S_T B_AY1 Deepak Chopra    B_EY1_S_T AA1_N AE2_L_AH0_G_EY1_SH_AH0_N_Z DH_AE1_T LifeVantage HH_AE1_D K_AH0_N_S_P_AY1_ER0_D W_IH1_DH F_AO1_R_M_ER0 Zrii IH0_G_Z_EH1_K_Y_AH0_T_IH0_V_Z T_UW1  “ R_UW1_AH0_N DH_AH0 K_AH1_M_P_AH0_N_IY2 ”  AH0_N_D T_EY1_K IH1_T OW1_V_ER0  “ AA1_N DH_AH0 CH_IY1_P ”  F_AA1_L_OW0_IH0_NG AH0  “ M_AE1_S EH1_K_S_AH0_D_AH0_S The K_EY1_S W_AA1_Z K_L_OW1_Z_D IH0_N December 2009 F_AA1_L_OW0_IH0_NG LifeVantage EH1_S S_EH1_T_AH0_L_M_AH0_N_T P_EY1_M_AH0_N_T AH1_V  $ 400 000 T_UW1 Zrii    On October 14    2011    Burke Hedges    AH0 F_AO1_R_M_ER0 LifeVantage D_IH0_S_T_R_IH1_B_Y_AH0_T_ER0    HH_AY1_ER0_D F_AO1_R HH_IH1_Z B_AE1_K_G_R_AW2_N_D AE1_Z AH0 S_P_IY1_K_ER0 AH0_N_D T_R_EY1_N_ER0    F_AY1_L_D AH0 L_AO1_S_UW2_T W_IH1_DH DH_AH0 Utah District Court AH0_G_EH1_N_S_T LifeVantage AH0_N_D IH1_T_S IH0_G_Z_EH1_K_Y_AH0_T_IH0_V_Z    S_IY1_K_IH0_NG  $ M_IH1_L_Y_AH0_N IH0_N P_Y_UW1_N_AH0_T_IH0_V D_AE1_M_AH0_JH_AH0_Z OW1_V_ER0 AE2_L_AH0_G_EY1_SH_AH0_N_Z AH1_V R_AO1_NG_F_AH0_L T_ER0_M_AH0_N_EY1_SH_AH0_N AH0_N_D tortious IH2_N_T_ER0_F_IH1_R_AH0_N_S    In September 2016    AH0 K_L_AE1_S AE1_K_SH_AH0_N L_AO1_S_UW2_T W_AA1_Z F_AY1_L_D AH0_G_EH1_N_S_T LifeVantage IH0_N Utah AH0_L_EH1_JH_IH0_NG DH_AE1_T DH_AH0 K_AH1_M_P_AH0_N_IY2 AH0_N_D IH1_T_S IH0_G_Z_EH1_K_Y_AH0_T_IH0_V Darren Jensen AH0_N_D Mark Jaggi M_EY1_D F_AO1_L_S AH0_N_D AO1_R M_IH0_S_L_IY1_D_IH0_NG S_T_EY1_T_M_AH0_N_T_S    AE1_Z W_EH1_L AE1_Z F_EY1_L_D T_UW1 D_IH0_S_K_L_OW1_Z M_AH0_T_IH1_R_IY0_AH0_L AE0_D_V_ER1_S F_AE1_K_T_S AH0_B_AW1_T DH_AH0 Company EH1_S B_IH1_Z_N_AH0_S    AA2_P_ER0_EY1_SH_AH0_N_Z    AH0_N_D P_R_AA1_S_P_EH0_K_T_S    Specifically    DH_AH0 K_EY1_S AH0_L_EH1_JH_D DH_AE1_T DH_AH0 D_IH0_F_EH1_N_D_AH0_N_T_S M_EY1_D F_AO1_L_S AH0_N_D AO1_R M_IH0_S_L_IY1_D_IH0_NG S_T_EY1_T_M_AH0_N_T_S AH0_N_D AO1_R F_EY1_L_D T_UW1 D_IH0_S_K_L_OW1_Z DH_AE1_T     AY1    LifeVantage L_AE1_K_T IH0_F_EH1_K_T_IH0_V IH2_N_T_ER1_N_AH0_L F_AH0_N_AE1_N_SH_AH0_L K_AH0_N_T_R_OW1_L_Z ;   ii    AE1_Z AH0 R_IH0_Z_AH1_L_T    DH_AH0 Company HH_AE1_D IH2_M_P_R_AA1_P_ER0_L_IY0 AH0_K_AW1_N_T_IH0_D F_AO1_R S_EY1_L_Z IH0_N S_ER1_T_AH0_N IH2_N_T_ER0_N_AE1_SH_AH0_N_AA0_L M_AA1_R_K_AH0_T_S    AH0_L_AO1_NG W_IH1_DH AH0_S_OW1_S_IY0_EY2_T_AH0_D R_EH1_V_AH0_N_UW2 AH0_N_D IH1_N_K_AH2_M T_AE1_K_S AH0_K_R_UW1_AH0_L_Z ;  AH0_N_D    iii    AE1_Z AH0 R_IH0_Z_AH1_L_T AH1_V DH_AH0 F_AO0_R_G_OW1_IH0_NG    LifeVantage EH1_S P_AH1_B_L_IH0_K S_T_EY1_T_M_AH0_N_T_S W_ER1 M_AH0_T_IH1_R_IY0_AH0_L_IY0 F_AO1_L_S AH0_N_D M_IH0_S_L_IY1_D_IH0_NG AE1_T AO1_L R_EH1_L_AH0_V_AH0_N_T T_AY1_M_Z     The K_EY1_S W_AA1_Z D_IH0_S_M_IH1_S_T IH0_N June 2017     In January 2018    AH0 K_L_AE1_S AE1_K_SH_AH0_N L_AO1_S_UW2_T W_AA1_Z F_AY1_L_D AH0_G_EH1_N_S_T LifeVantage IH0_N Connecticut AH0_L_EH1_JH_IH0_NG DH_AE1_T DH_AH0 K_AH1_M_P_AH0_N_IY2 AH0_N_D IH1_T_S Chief Executive Officer Darren Jensen    Chief Sales Officer Justin Rose    AH0_N_D Chief Marketing Officer Ryan Goodwin W_ER1 AA1_P_ER0_EY2_T_IH0_NG AE1_N IH2_L_IY1_G_AH0_L P_IH1_R_AH0_M_IH0_D S_K_IY1_M IH0_N V_AY0_AH0_L_EY1_SH_AH0_N AH1_V DH_AH0 RICO Act    F_EH1_D_ER0_AH0_L S_IH0_K_Y_UH1_R_AH0_T_IY0_Z L_AO1_Z    AH0_N_D DH_AH0 Connecticut Unfair Trade Practices Act    Major League Soccer T_IY1_M Real Salt Lake AH0_N_AW1_N_S_T AA1_N October 29    2013 DH_AE1_T IH1_T HH_AE1_D partnered W_IH1_DH LifeVantage F_AO1_R AH0 L_AO1_NG T_ER1_M    M_AH2_L_T_AY2_M_IH1_L_Y_AH0_N D_AA1_L_ER0 JH_ER1_Z_IY0 F_R_AH1_N_T S_P_AA1_N_S_ER0_SH_IH2_P The P_AA1_R_T_N_ER0_SH_IH2_P W_AA1_Z S_EH1_T T_UW1 F_AO1_R_M_AH0_L_IY0 G_OW1 IH1_N_T_UW0 IH0_F_EH1_K_T AA1_N January    2014    W_IH1_DH DH_AH0 LifeVantage L_OW1_G_OW0 AH0_P_IH1_R_IH0_NG AA1_N DH_AH0 Real Salt Lake JH_ER1_Z_IY0 S_T_AA1_R_T_IH0_NG IH0_N DH_AH0 N_EH1_K_S_T S_IY1_Z_AH0_N    In July 2015    Real Salt Lake OW1_N_ER0 Dell Loy Hansen W_AA1_Z R_IY2_P_AO1_R_T_AH0_D B_AY1 DH_AH0 Securities AH0_N_D Exchange Commission T_UW1 HH_AE1_V B_AA1_T AH0 P_ER0_S_EH1_N_T OW1_N_ER0_SH_IH2_P S_T_EY1_K IH0_N LifeVantage   